Intelligent Bio Solutions (INBS) Net Income towards Common Stockholders (2019 - 2025)

Intelligent Bio Solutions' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2025.

• In Q1 2025, Net Income towards Common Stockholders rose 14.58% year-over-year to -$2.6 million; the TTM figure through Jun 2025 stood at -$7.5 million (up 27.74% YoY), while the FY2024 annual figure was -$10.3 million, up 18.29% from the prior year.
• Net Income towards Common Stockholders was -$2.6 million for Q1 2025 at Intelligent Bio Solutions, down from -$2.3 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$850230.0 in Q2 2021 to a low of -$6.4 million in Q1 2023.
• Historically, Net Income towards Common Stockholders has averaged -$2.5 million across 5 years, with a median of -$2.6 million in 2025.
• The sharpest annual moves came in 2021 and 2022: Net Income towards Common Stockholders sank 2728.5% in 2021, then surged 57.23% in 2022.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$3.5 million in 2021, then jumped by 38.52% to -$2.1 million in 2022, then gained by 5.13% to -$2.0 million in 2023, then decreased by 11.67% to -$2.3 million in 2024, then fell by 13.05% to -$2.6 million in 2025.
• The last three Net Income towards Common Stockholders figures came in at -$2.6 million (Q1 2025), -$2.3 million (Q4 2024), and -$2.7 million (Q3 2024), per Business Quant data.